股本结构
单位：万股
| 公告日期 | 2026-05-14 | 2026-02-12 | 2026-02-12 | 2025-11-06 | 2025-08-08 | 2025-08-08 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3077.67 | 3063.18 | 3057.17 | 3049.31 | 2701.89 | 2661.89 |
| 普通股本 | 3077.67 | 3063.18 | 3057.17 | 3049.31 | 2701.89 | 2661.89 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2026-03-31 | 2026-02-06 | 2025-12-31 | 2025-09-30 | 2025-08-08 | 2025-08-04 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2026-05-14 | 3077.67 | 未披露 |
更多>>
From December 31,2025 to March 31,2026
Issuance of common stock due to exercise of penny warrants
Vesting of restricted stock units
|
2026-03-31 |
| 2026-02-12 | 3063.18 | 未披露 | 定期报告 | 2026-02-06 |
| 2026-02-12 | 3057.17 | 未披露 |
更多>>
From December 31, 2024 to December 31, 2025
Issuance of common stock under private placement
Issuance of common stock related to debt amendment
Vesting of restricted stock units
Exercise of stock options
ESPP purchase
Vesting of Company common stock held by the NQDC Plan
|
2025-12-31 |
| 2025-11-06 | 3049.31 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Issuance of common stock under private placement
Issuance of common stock related to debt amendment
Vesting of restricted stock units
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
|
2025-09-30 |
| 2025-08-08 | 2701.89 | 未披露 |
更多>>
Common Stock offered 400,000 shares by the company
|
2025-08-08 |
| 2025-08-08 | 2661.89 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-08-08 | 2661.37 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Vesting of restricted stock units
Exercise of stock options
ESPP purchase
|
2025-06-30 |
| 2025-05-08 | 2643.47 | 未披露 |
更多>>
From December 31, 2024 to March 31, 2025
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
|
2025-03-31 |
| 2025-02-13 | 2635.75 | 未披露 | 定期报告 | 2025-02-07 |
| 2025-02-13 | 2635.40 | 未披露 |
更多>>
From December 31, 2023 to December 31, 2024
Vesting of restricted stock units
ESPP purchase
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
|
2024-12-31 |
| 2024-11-07 | 2621.76 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Vesting of restricted stock units
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
|
2024-09-30 |
| 2024-08-08 | 2598.97 | 未披露 | 定期报告 | 2024-08-04 |
| 2024-08-08 | 2594.99 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Vesting of restricted stock units
Exercise of stock options
ESPP purchase
|
2024-06-30 |
| 2024-04-23 | 2579.97 | 未披露 | 定期报告 | 2024-04-11 |
| 2024-05-13 | 2578.91 | 未披露 |
更多>>
From December 31, 2023 to March 31, 2024
Exercise of stock options
|
2024-03-31 |
| 2024-02-22 | 2570.67 | 未披露 | 定期报告 | 2024-02-07 |
| 2024-02-22 | 2570.66 | 未披露 | 定期报告 | 2024-01-31 |
| 2024-02-22 | 2568.21 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Exercise of stock options
Vesting of restricted stock units
Company common stock held by the NQDC Plan
ESPP purchases
|
2023-12-31 |
| 2023-11-09 | 2555.07 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of restricted stock units
Company common stock held by the NQDC Plan
|
2023-09-30 |
| 2023-08-10 | 2547.83 | 未披露 | 定期报告 | 2023-08-02 |
| 2023-08-10 | 2544.76 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options
Vesting of restricted stock units
|
2023-06-30 |
| 2023-05-11 | 2532.78 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Company common stock held by the NQDC Plan
Change in redemption value of share awards in NQDC plan
|
2023-03-31 |
| 2023-04-14 | 2532.78 | 未披露 | 定期报告 | 2023-03-27 |
| 2023-02-23 | 2529.61 | 未披露 | 定期报告 | 2023-02-13 |
| 2023-02-23 | 2520.84 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Vesting of restricted stock units
Company common stock held by the NQDC
Exercise of stock options
|
2022-12-31 |
| 2022-11-10 | 2503.09 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units
Company common stock held by the NQDC
|
2022-09-30 |
| 2022-08-11 | 2500.31 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of restricted stock units
|
2022-06-30 |
| 2022-05-12 | 2495.56 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Exercise of stock options
Vesting of restricted stock units
|
2022-03-31 |
| 2022-02-28 | 2492.57 | 未披露 |
更多>>
From June 30, 2021 to December 31, 2021
Exercise of stock options
Vesting of restricted stock units
|
2021-12-31 |
| 2021-11-08 | 2492.51 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Exercise of stock options
Vesting of restricted stock units
|
2021-09-30 |
| 2021-08-26 | 2489.59 | 未披露 |
更多>>
From June 30, 2020 to June 30, 2021
Issuance of common stock under direct placement
Exercise of stock options
Vesting of restricted stock units
|
2021-06-30 |
| 2021-05-13 | 2484.29 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Issuance of common stock under direct placement
Exercise of stock options
|
2021-03-31 |
| 2021-03-01 | 2442.01 | 未披露 |
更多>>
1.Common stock offered by the company 2,795,000 shares.
2.Unless the company indicate otherwise, the number of shares of common stock to be outstanding after this offering is based on 21,625,058 shares of common stock outstanding as of December 31, 2020.
|
2021-03-01 |
| 2021-02-16 | 2162.86 | 未披露 | 定期报告 | 2021-02-13 |
| 2021-02-16 | 2162.51 | 未披露 |
更多>>
From September 30,2020 to December 31,2020
Exercise of stock options
|
2020-12-31 |
| 2020-11-10 | 2162.33 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of stock options
Vesting of RSU options
|
2020-09-30 |
| 2020-09-25 | 2155.18 | 未披露 | 定期报告 | 2020-09-10 |
| 2020-08-27 | 2146.85 | 未披露 | 定期报告 | 2020-08-20 |
| 2020-08-27 | 2146.79 | 未披露 |
更多>>
From June 30, 2019 to June 30, 2020
Issuance of common stock under direct placement
Exercise of stock options
Vesting of RSU options
Issuance of common stock to director in lieu of directors fees
On June 30, 2020 (the “Effective Date”), the redomiciliation (“Redomiciliation”) of Avita Medical Limited, a public company incorporated under the laws of the State of Victoria Australia (“Avita Australia”) was completed in accordance with the Scheme Implementation Agreement, dated April 20, 2020, between Avita Australia and Avita Therapeutics, Inc., a Delaware corporation (the “Company”). The Redomiciliation was effected pursuant to a statutory scheme of arrangement under Australian law (the “Scheme”), whereby on the Effective Date, all of the issued and outstanding ordinary shares of Avita Australia were exchanged for newly issued shares of common stock of the Company, on the basis of one share of the Company’s common stock for every 100 ordinary shares of Avita Australia issued and outstanding.
|
2020-06-30 |
| 2020-04-20 | 213343.49 | 未披露 | 定期报告 | 2020-04-20 |
| 2020-02-19 | 211747.43 | 未披露 |
更多>>
from July 1, 2019 to December 31, 2019
Issue of shares
|
2019-12-31 |
| 2019-10-31 | 187129.96 | 未披露 |
更多>>
from July 1, 2018 to June 30, 2019
New shares
|
2019-06-30 |
From December 31,2025 to March 31,2026
Issuance of common stock due to exercise of penny warrants
Vesting of restricted stock units
From December 31, 2024 to December 31, 2025
Issuance of common stock under private placement
Issuance of common stock related to debt amendment
Vesting of restricted stock units
Exercise of stock options
ESPP purchase
Vesting of Company common stock held by the NQDC Plan
From June 30, 2025 to September 30, 2025
Issuance of common stock under private placement
Issuance of common stock related to debt amendment
Vesting of restricted stock units
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
Common Stock offered 400,000 shares by the company
From March 31, 2025 to June 30, 2025
Vesting of restricted stock units
Exercise of stock options
ESPP purchase
From December 31, 2024 to March 31, 2025
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
From December 31, 2023 to December 31, 2024
Vesting of restricted stock units
ESPP purchase
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
From June 30, 2024 to September 30, 2024
Vesting of restricted stock units
Exercise of stock options
Vesting of Company common stock held by the NQDC Plan
From March 31, 2024 to June 30, 2024
Vesting of restricted stock units
Exercise of stock options
ESPP purchase
From December 31, 2023 to March 31, 2024
Exercise of stock options
From December 31, 2022 to December 31, 2023
Exercise of stock options
Vesting of restricted stock units
Company common stock held by the NQDC Plan
ESPP purchases
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of restricted stock units
Company common stock held by the NQDC Plan
From March 31, 2023 to June 30, 2023
Exercise of stock options
Vesting of restricted stock units
From December 31, 2022 to March 31, 2023
Company common stock held by the NQDC Plan
Change in redemption value of share awards in NQDC plan
From December 31, 2021 to December 31, 2022
Vesting of restricted stock units
Company common stock held by the NQDC
Exercise of stock options
From June 30, 2022 to September 30, 2022
Vesting of restricted stock units
Company common stock held by the NQDC
From March 31, 2022 to June 30, 2022
Vesting of restricted stock units
From December 31, 2021 to March 31, 2022
Exercise of stock options
Vesting of restricted stock units
From June 30, 2021 to December 31, 2021
Exercise of stock options
Vesting of restricted stock units
From June 30, 2021 to September 30, 2021
Exercise of stock options
Vesting of restricted stock units
From June 30, 2020 to June 30, 2021
Issuance of common stock under direct placement
Exercise of stock options
Vesting of restricted stock units
From December 31, 2020 to March 31, 2021
Issuance of common stock under direct placement
Exercise of stock options
1.Common stock offered by the company 2,795,000 shares.
2.Unless the company indicate otherwise, the number of shares of common stock to be outstanding after this offering is based on 21,625,058 shares of common stock outstanding as of December 31, 2020.
From September 30,2020 to December 31,2020
Exercise of stock options
From June 30, 2020 to September 30, 2020
Exercise of stock options
Vesting of RSU options
From June 30, 2019 to June 30, 2020
Issuance of common stock under direct placement
Exercise of stock options
Vesting of RSU options
Issuance of common stock to director in lieu of directors fees
On June 30, 2020 (the “Effective Date”), the redomiciliation (“Redomiciliation”) of Avita Medical Limited, a public company incorporated under the laws of the State of Victoria Australia (“Avita Australia”) was completed in accordance with the Scheme Implementation Agreement, dated April 20, 2020, between Avita Australia and Avita Therapeutics, Inc., a Delaware corporation (the “Company”). The Redomiciliation was effected pursuant to a statutory scheme of arrangement under Australian law (the “Scheme”), whereby on the Effective Date, all of the issued and outstanding ordinary shares of Avita Australia were exchanged for newly issued shares of common stock of the Company, on the basis of one share of the Company’s common stock for every 100 ordinary shares of Avita Australia issued and outstanding.
from July 1, 2019 to December 31, 2019
Issue of shares
from July 1, 2018 to June 30, 2019
New shares